No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CA Stock MarketDetailed Quotes
MRVL Marvel Biosciences Corp
- 0.150
- 0.0000.00%
15min DelayMarket Closed Dec 16 16:00 ET
6.72MMarket Cap-3.75P/E (TTM)
0.150High0.145Low6.50KVolume0.145Open0.150Pre Close955.00Turnover0.19052wk High0.02%Turnover Ratio44.79MShares0.06052wk Low-0.04EPS TTM5.60MFloat Cap0.390Historical HighLossP/E (Static)37.35MShs Float0.010Historical Low-0.04EPS LYR3.33%Amplitude--Dividend TTM-2.38P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Marvel Biosciences Corp: MDA EN
Marvel Biosciences Corp: AUDITED ANNUAL FINANCIAL STATEMENTS EN
Marvel Biosciences Announces Promising New Data From Rett Syndrome Study and Plans to Discuss Orphan and Rare Disease Status With the FDA
Marvel Biosciences Secures $300,000 Grant to Advance Groundbreaking Alzheimer's Research
Marvel Biosciences Corp. to Present at the Life Sciences Investor Forum November 14th
Marvel Biosciences Shares Positive Results of MB204 in the Oprm1 Model of Autism